Gemtuzumab
220578-59-6 Basic informationMore
- Product Name:Gemtuzumab
- Synonyms: Gemtuzumab Cdp 771 Gemtuzumab ozogamicin Gemtuzumab ozogamicin [usan] Immunoglobulin G4 (anti-(human cd33 (antigen)) (human-mouse monoclonal hp67.6 gamma4-chain)), disulfide with human-mouse monoclonal hp67 6kappa-chain, dimer, methyl ((1R,4Z,8S,13E)-8-((2-o-(4-(acetylethylamino)-2,4-dideoxy-3-o-methyl-alpha-L-threo-pentopyranosyl)-4,6-dideoxy-4-(((2,6-dideoxy-4-S-(4-((6-deoxy-3-o-methyl-alpha-L-mannopyranosyl)oxy)-3-iodo-5,6-dimethoxy-2-methylbenzoyl)-4-thio-beta-D-ribo-hexopyranosyl)oxy)amino)-beta-D-glucopyranosyl)oxy)-13-(2-((3-((1-(4-(4-amino-4-oxobutoxy)phenyl)ethylidene)hydrazino)-1,1-dimethyl-3-oxopropyl)dithio)ethylidene)-1-hydroxy-11-oxobicyclo(7.3.1) Unii-8gzg754X6m Way-cma 676 Research Grade Gemtuzumab(DHD37501)
- CAS:220578-59-6
- MF:
- MW:0
- EINECS:
- Mol File:Mol File
-
USE
Gemtuzumab ozogamicin (Mylotarg, fusion molecule) isan MAb derived from the CD33 antigen, a sialic aciddependentadhesion protein expressed on the surface ofleukemia blasts and immature normal cells of myelomonocyticorigin but not on normal hematopoietic stem cells. Gemtuzumab ozogamicin is indicated for the treatmentof patients with CD33-positive acute myeloid leukemia infirst relapse among adults 60 years of age or older who arenot considered candidates for cytotoxic chemotherapy.Gemtuzumab ozogamicin binds to the CD33 antigen expressedby hematopoietic cells. This antigen is expressed onthe surface of leukemic blasts in more than 80% of patientswith acute myeloid leukemia. CD33 is also expressed onnormal and leukemic myeloid colony-forming cells, includingleukemic clonogenic precursors, but it is not expressedon pluripotent hematopoietic stem cells or nonhematopoieticcells. Binding of the anti-CD33 antibody results in acomplex that is internalized. On internalization thecalicheamicin derivative is released inside the lysosomes ofthe myeloid cells. The released calicheamicin derivativebinds to the minor groove of DNA and causes double-strandbreaks and cell death.
Browse by Nationality 220578-59-6 Suppliers >Global suppliers
Beijing (1) Shanghai (4) Zhejiang (1) Hunan (1) Hubei (7) Henan (1) Member (15) All (15)
Please select the suppliers
Recommend You Select Member Companies
Recommend You Select Member Companies
- Company Name:Shanghai EFE Biological Technology Co., Ltd.
- Tel:021-65675885 18964387627
- Products Intro:Product Name:Gemtuzumab
CAS:220578-59-6
Purity:95% Package:2mg;5mg;10mg More... - CB Index:58
- Related Information:Catalog(9806)
- Company Name:ShangHai Biochempartner Co.,Ltd
- Tel:17754423994 17754423994
- Products Intro:Product Name:Gemtuzumab
CAS:220578-59-6
Purity:95% Package:100ug;500ug;1mg - CB Index:62
- Related Information:Catalog(8011)
- Company Name:Wuhan Chemstan Biotechnology Co., Ltd.
- Tel:027-65317797 15926423062
- Products Intro:Product Name:Gemtuzumab Ozogamicin
Purity:>95%;1mg/ml Package:200ug;500ug;1mg - CB Index:58
- Related Information:Catalog(10457)
- Company Name:Hubei Kele Fine Chemical Co., Ltd
- Tel:027-59101668 19945030958
- Products Intro:Product Name:Gemtuzumab
CAS:220578-59-6
Purity:98% HPLC Package:5KG;1KG;100g;1g - CB Index:58
- Related Information:Catalog(7890)
- Company Name:Wuhan Yingnuo Pharmaceutical Technology Co., Ltd.
- Tel:+86-027-59232304 15387063101
- Products Intro:Product Name:Gemtuzumab
CAS:220578-59-6
Purity:98% Package:1KG；100g;1g,100mg - CB Index:58
- Related Information:Catalog(9996)
- Company Name:Biolab Reagents
- Tel:027-65279366 18108604862
- Products Intro:Product Name:Research Grade Gemtuzumab(DHD37501)
CAS:220578-59-6
Purity:PAGE:>95% Package:100ug;1mg - CB Index:58
- Related Information:Catalog(9818)